KONZENTRIERTE PROTEINFORMULIERUNGEN
European patent · EP2542221 · In force
Register entry
- Publication number
- EP2542221
- Application number
- EP11751179
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 1, 2011
- Published
- Jan 9, 2013
- Granted
- May 27, 2026
- Protection ends at the latest
- Feb 28, 2031
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 9/08 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)A61P 31/18 (2006.01)A61K 47/18 (2017.01)C07K 16/00 (2006.01)A61K 9/00 (2006.01)A61K 47/26 (2006.01)C07K 16/28 (2006.01)A61P 31/14 (2006.01)
- Priority
- US 339191 P 01.03.2010
- PCT application
- PCT/US2011/026647 01.03.2011
- PCT publication
- WO2011/109365 09.09.2011
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 17, 2026
Change
Published in Swissreg on 17.06.2026
- May 28, 2026
Owner
- Owner
- CytoDyn, Inc., 5 Centerpointe Drive, Suite 400, Lake Oswego, OR 97035, USA → CytoDyn Inc., 1111 Main Street, Suite 660, Vancouver, WA 98660, USA
Published in Swissreg on 28.05.2026
- May 27, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 27.05.2026
Parties
Inventor
CHEN, Tracy, T.
Katonah New York 10536, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.